Unlocking the potential for optic nerve regeneration over long distances: a multi-therapeutic intervention.

IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY
Frontiers in Neurology Pub Date : 2025-01-09 eCollection Date: 2024-01-01 DOI:10.3389/fneur.2024.1526973
Zhen-Gang Liu, Lai-Yang Zhou, Yong-Quan Sun, Yi-Hang Ma, Chang-Mei Liu, Bo-Yin Zhang
{"title":"Unlocking the potential for optic nerve regeneration over long distances: a multi-therapeutic intervention.","authors":"Zhen-Gang Liu, Lai-Yang Zhou, Yong-Quan Sun, Yi-Hang Ma, Chang-Mei Liu, Bo-Yin Zhang","doi":"10.3389/fneur.2024.1526973","DOIUrl":null,"url":null,"abstract":"<p><p>Retinal ganglion cells (RGCs) generally fail to regenerate axons, resulting in irreversible vision loss after optic nerve injury. While many studies have shown that modulating specific genes can enhance RGCs survival and promote optic nerve regeneration, inducing long-distance axon regeneration <i>in vivo</i> through single-gene manipulation remains challenging. Nevertheless, combined multi-gene therapies have proven effective in significantly enhancing axonal regeneration. At present, research on promoting optic nerve regeneration remains slow, with most studies unable to achieve axonal growth beyond the optic chiasm or reestablish connections with the brain. Future research priorities include directing axonal growth along correct pathways, facilitating synapse formation and myelination, and modifying the inhibitory microenvironment. These strategies are crucial not only for optic nerve regeneration but also for broader applications in central nervous system repair. In this review, we discuss multifactors therapeutic strategies for optic nerve regeneration, offering insights into advancing nerve regeneration research.</p>","PeriodicalId":12575,"journal":{"name":"Frontiers in Neurology","volume":"15 ","pages":"1526973"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754882/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fneur.2024.1526973","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Retinal ganglion cells (RGCs) generally fail to regenerate axons, resulting in irreversible vision loss after optic nerve injury. While many studies have shown that modulating specific genes can enhance RGCs survival and promote optic nerve regeneration, inducing long-distance axon regeneration in vivo through single-gene manipulation remains challenging. Nevertheless, combined multi-gene therapies have proven effective in significantly enhancing axonal regeneration. At present, research on promoting optic nerve regeneration remains slow, with most studies unable to achieve axonal growth beyond the optic chiasm or reestablish connections with the brain. Future research priorities include directing axonal growth along correct pathways, facilitating synapse formation and myelination, and modifying the inhibitory microenvironment. These strategies are crucial not only for optic nerve regeneration but also for broader applications in central nervous system repair. In this review, we discuss multifactors therapeutic strategies for optic nerve regeneration, offering insights into advancing nerve regeneration research.

Abstract Image

Abstract Image

Abstract Image

释放视神经长距离再生的潜力:一种多疗法干预。
视网膜神经节细胞(RGCs)通常不能再生轴突,导致视神经损伤后不可逆的视力丧失。虽然许多研究表明,调节特定基因可以提高RGCs的存活并促进视神经再生,但通过单基因操纵诱导体内远距离轴突再生仍然具有挑战性。然而,联合多基因疗法已被证明在显著增强轴突再生方面有效。目前,关于促进视神经再生的研究进展缓慢,大多数研究无法实现视神经交叉以外的轴突生长或重建与大脑的连接。未来的研究重点包括引导轴突沿着正确的路径生长,促进突触形成和髓鞘形成,以及改变抑制微环境。这些策略不仅对视神经再生至关重要,而且在中枢神经系统修复方面也有更广泛的应用。在这篇综述中,我们讨论了视神经再生的多因素治疗策略,为推进神经再生研究提供了一些见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Neurology
Frontiers in Neurology CLINICAL NEUROLOGYNEUROSCIENCES -NEUROSCIENCES
CiteScore
4.90
自引率
8.80%
发文量
2792
审稿时长
14 weeks
期刊介绍: The section Stroke aims to quickly and accurately publish important experimental, translational and clinical studies, and reviews that contribute to the knowledge of stroke, its causes, manifestations, diagnosis, and management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书